Pharma stocks traded broadly higher in early deals on February 3, tracking strong momentum across the sector.
As of 9:32 am, Aurobindo Pharma was trading at ₹1,229.10, up 4.96%, while Dr Reddy’s Laboratories gained 4.17% to ₹1,231.80. Divi’s Laboratories rose 3.73% to ₹6,174.50, and Sun Pharmaceutical Industries advanced 3.55% to ₹1,685.70.
Other major pharma names also posted solid gains. Glenmark Pharmaceuticals climbed 2.81%, Mankind Pharma rose 2.97%, and Zydus Lifesciences gained 2.69%. Alkem Laboratories traded 2.67% higher, while GlaxoSmithKline Pharmaceuticals was up 2.54%.
Further, Lupin added 2.19%, Cipla rose 2.05%, and Biocon gained 1.80%. Torrent Pharmaceuticals advanced 1.25%, Abbott India was up 0.82%, and IPCA Laboratories edged higher by 0.53%.
The gains reflect broad-based buying across large-cap and mid-cap pharmaceutical stocks in the morning session.
Disclaimer: Data as of 9:23 am on February 3. It does not constitute investment advice or a recommendation to buy or sell any securities.
